Skip to content

Drugs Made In America Acquisition Corp.

DMAA· NasdaqCore metricsCIK 2028614

Blank check companies302 peers

Last sale
Nov 12, 2026
Market cap
$264.62M
24.28M shares
Filings
81
—
—
—
$1.73M
Q2 2026
—
-$136.93K
Q2 2026
—
—
—
—
-$0.03
FY 2024
—
$20.28K
Q2 2026+354.3% FY25 yoy
$264.62M
44.5×
—
—
—
—

FY2025 figures · derived

Price

$10.90+5.21%+$0.54since Nov 21, 2025
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

General And Administrative

$2.82MFY 2025
$2.82M0FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,816,013reported

Blank check companies

Drugs Made In America Acquisition Corp. is the 140th largest of the 303 covered companies the SEC files under this code, by market cap. SIC 6770

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Drugs Made In America Acquisition Corp. · CIK 2028614 · Engraved from SEC EDGAR